Settle® IV Solution

VETOQUINOL USA INC

Description

SETTLE® is the world’s first and only immunotherapeutic licensed to treat equine endometritis - one of the root causes of poor conception rates. Supportive research has demonstrated positive results not only for rapidly resolving uterine infection, but also improving overall uterine health. The USDA has approved SETTLE® as an aid in the treatment of equine endometritis caused by Streptococcus zooepidemicus. Powerful as a stand-alone therapy, SETTLE® can be effectively integrated with standard treatment regimens that include antibiotics and uterine lavage. Ten reasons to consider SETTLE® for your problem mares:
  • A new technological approach for a costly, industry-wide reproduction problem
  • Normalizes sub-optimal responses to infection and endometritis in problem mares
  • Proven both safe and effective in U.S. mares over past two breeding seasons
  • Works as a stand alone treatment or hand-in-hand with other therapies to synergistically improve treat
Additional Information
DEA
Hazmat - Chargeable
Ice
List 1
MSDS
My eCustom Catalog
Hazmat - No Charge
Pedigree
Prescription
Promotion
This item is on your Formulary list.
New Arrivals